MCCULLOCH KEVIN (See Remarks) sold 1.5% of their position (25K shares) of XERIS BIOPHARMA HOLDINGS, INC. on the open market
Open‑market sale worth $250.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/29/2026ACC: 0001867096-26-000078
Officer· See Remarks
Since Mar 2026
-25K
Net shares
Net seller
$250.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
25K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−25K
Price / share
$10.00
Trade value
$250K
% of position
1.5%
9/28/2026
1.64M→1.61M
Total
Net shares
−25K
Net value
-$250K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/28/2026 | S · Sale | −25K | $10.00 | $250K | 1.5% | 1.64M | 1.61M |
| Total | −25K | -$250K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned25K
Total
25K indirect25K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 25K | Indirect |
| Total | 25K | 25K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported